Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06621758
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study investigate what information individuals with SCD or MCI and their co-participant would like to receive during pre-diagnostic counseling and diagnostic disclosure and how this information should be conveyed
Detailed Description:
Improved diagnostic work-up and the introduction of disease-modifying treatment have led to a shift towards earlier diagnosis However there are a need for better understanding of how best to communicate about biomarker use assessment and results in individuals with subjective cognitive decline SCD and mild cognitive impairment MCI
Objective
The overarching objective of this study is
To understand what information individuals with SCD or MCI and their co-participant would like to receive during pre-diagnostic counseling and diagnostic disclosure and how this information should be conveyed
Methods a prospective survey study Persons diagnosed with SCD or MCI and co-participants will be recruited consecutively from the memory clinic Copenhagen University Hospital - Rigshospitalet Denmark Toulouse University Hospital France University Medical Centre Ljubljana Slovenia and Universitair Ziekenhuis Brussel Belgium
Approximately 30 persons and respective co-participants will be included from each hospital over a period of 12 months
Each participating person and co-participant will be asked to complete a very brief questionnaire immediately after disclosure of the diagnosis and another questionnaire 2-6 weeks after the disclosure visit
Objective
The overarching objective of this study is
To understand what information individuals with SCD or MCI and their co-participant would like to receive during pre-diagnostic counseling and diagnostic disclosure and how this information should be conveyed
Methods a prospective survey study Persons diagnosed with SCD or MCI and co-participants will be recruited consecutively from the memory clinic Copenhagen University Hospital - Rigshospitalet Denmark Toulouse University Hospital France University Medical Centre Ljubljana Slovenia and Universitair Ziekenhuis Brussel Belgium
Approximately 30 persons and respective co-participants will be included from each hospital over a period of 12 months
Each participating person and co-participant will be asked to complete a very brief questionnaire immediately after disclosure of the diagnosis and another questionnaire 2-6 weeks after the disclosure visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None